Biomark Diagnostics Statistics

Total Valuation

CSE:BUX has a market cap or net worth of CAD 31.18 million. The enterprise value is 30.09 million.

Market Cap	31.18M
Enterprise Value	30.09M

Important Dates

The next estimated earnings date is Thursday, November 27, 2025.

Earnings Date	Nov 27, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	105.09M
Shares Outstanding	n/a
Shares Change (YoY)	+8.42%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	53.57M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	201.30
PB Ratio	23.42
P/TBV Ratio	23.42
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-17.50
EV / Sales	190.89
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-28.36

Financial Position

The company has a current ratio of 1.85, with a Debt / Equity ratio of 0.77.

Current Ratio	1.85
Quick Ratio	1.85
Debt / Equity	0.77
Debt / EBITDA	n/a
Debt / FCF	-0.97
Interest Coverage	-35.78

Financial Efficiency

Return on equity (ROE) is -504.79% and return on invested capital (ROIC) is -71.73%.

Return on Equity (ROE)	-504.79%
Return on Assets (ROA)	-62.79%
Return on Invested Capital (ROIC)	-71.73%
Return on Capital Employed (ROCE)	-128.50%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.08
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +39.58% in the last 52 weeks. The beta is -0.32, so CSE:BUX's price volatility has been lower than the market average.

Beta (5Y)	-0.32
52-Week Price Change	+39.58%
50-Day Moving Average	0.34
200-Day Moving Average	0.29
Relative Strength Index (RSI)	47.63
Average Volume (20 Days)	19,842

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, CSE:BUX had revenue of CAD 154,895 and -1.72 million in losses. Loss per share was -0.02.

Revenue	154,895
Gross Profit	154,895
Operating Income	-1.84M
Pretax Income	-1.72M
Net Income	-1.72M
EBITDA	-1.82M
EBIT	-1.84M
Loss Per Share	-0.02

Full Income Statement

Balance Sheet

The company has 2.09 million in cash and 1.03 million in debt, giving a net cash position of 1.07 million.

Cash & Cash Equivalents	2.09M
Total Debt	1.03M
Net Cash	1.07M
Net Cash Per Share	n/a
Equity (Book Value)	1.33M
Book Value Per Share	0.01
Working Capital	1.04M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -1.06 million and capital expenditures -3,030, giving a free cash flow of -1.06 million.

Operating Cash Flow	-1.06M
Capital Expenditures	-3,030
Free Cash Flow	-1.06M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	100.00%
Operating Margin	-1,188.12%
Pretax Margin	-1,110.44%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

CSE:BUX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-8.42%
Shareholder Yield	-8.42%
Earnings Yield	-5.52%
FCF Yield	-3.40%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

CSE:BUX has an Altman Z-Score of -1.35 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-1.35
Piotroski F-Score	2